

(Sharecast News) - Drug discovery company C4X announced the appointment of Nick Ray as its chief scientific officer on Tuesday, with immediate effect.


(Alliance News) - C4X Discovery Holdings PLC on Tuesday said it appointed a new scientific officer, promoting internally.


(Alliance News) - C4X Discovery Holdings PLC on Thursday said its annual loss widened, but it remains positive in its outlook, citing a partner progra...


(Sharecast News) - Drug discovery specialist C4X has signed an exclusive worldwide licensing agreement with AstraZeneca worth up to $402m, it announce...


(Alliance News) - Stock prices in London were in the red on Monday, as protests across China against its strict Covid policies undermined global risk ...


(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.


(Alliance News) - C4X Discovery Holdings PLC on Monday said it signed an exclusive worldwide licensing agreement with AstraZeneca PLC for its NRF2 Act...